Literature DB >> 17251015

Opioids and efflux transporters. Part 1: P-glycoprotein substrate activity of N-substituted analogs of meperidine.

Susan L Mercer1, Hazem E Hassan, Christopher W Cunningham, Natalie D Eddington, Andrew Coop.   

Abstract

P-Glycoprotein (P-gp) is an efflux transporter which is up-regulated at the blood-brain barrier in both morphine- and oxycodone-tolerant rats. Numerous studies have shown that many clinically employed opioid analgesics are substrates for P-gp, suggesting that up-regulation of P-gp may contribute to the development of central tolerance to opioids. The studies herein focus on the development of SAR for P-gp substrate activity in the meperidine series of compounds, and show that a meperidine analog of greater potency, N-phenylbutyl-N-normeperidine, has low activity as a P-gp substrate and has the potential to be utilized as a tool to study the contribution of P-gp to the development of central tolerance to opioids.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17251015      PMCID: PMC1850229          DOI: 10.1016/j.bmcl.2006.12.042

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  13 in total

Review 1.  Opioid tolerance-in search of the holy grail.

Authors:  Brigitte L Kieffer; Christopher J Evans
Journal:  Cell       Date:  2002-03-08       Impact factor: 41.582

Review 2.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

Authors:  S V Ambudkar; S Dey; C A Hrycyna; M Ramachandra; I Pastan; M M Gottesman
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

Review 3.  Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review.

Authors:  Ewan McNicol; Nathalie Horowicz-Mehler; Ruth A Fisk; Kyle Bennett; Maria Gialeli-Goudas; Priscilla W Chew; Joseph Lau; Daniel Carr
Journal:  J Pain       Date:  2003-06       Impact factor: 5.820

Review 4.  Multiple opiate receptors: déjà vu all over again.

Authors:  Gavril W Pasternak
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

Review 5.  Insights into opioid action in the intestinal tract.

Authors:  A De Luca; I M Coupar
Journal:  Pharmacol Ther       Date:  1996       Impact factor: 12.310

6.  Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy.

Authors:  S McLamore; T Ullrich; R B Rothman; H Xu; C Dersch; A Coop; P Davis; F Porreca; A E Jacobson; K C Rice
Journal:  J Med Chem       Date:  2001-04-26       Impact factor: 7.446

7.  Increased brain P-glycoprotein in morphine tolerant rats.

Authors:  C L Aquilante; S P Letrent; G M Pollack; K L Brouwer
Journal:  Life Sci       Date:  2000       Impact factor: 5.037

8.  The role of P-glycoprotein in blood-brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (-/-) and mdr1a (+/+) mice.

Authors:  R Xie; M Hammarlund-Udenaes; A G de Boer; E C de Lange
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

Review 9.  P-glycoprotein: from genomics to mechanism.

Authors:  Suresh V Ambudkar; Chava Kimchi-Sarfaty; Zuben E Sauna; Michael M Gottesman
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

10.  Variable modulation of opioid brain uptake by P-glycoprotein in mice.

Authors:  Claude Dagenais; Candace L Graff; Gary M Pollack
Journal:  Biochem Pharmacol       Date:  2004-01-15       Impact factor: 5.858

View more
  11 in total

1.  Nitrile analogs of meperidine as high affinity and selective sigma-1 receptor ligands.

Authors:  Susan L Mercer; Jamaluddin Shaikh; John R Traynor; Rae R Matsumoto; Andrew Coop
Journal:  Eur J Med Chem       Date:  2007-10-06       Impact factor: 6.514

2.  Differential involvement of P-glycoprotein (ABCB1) in permeability, tissue distribution, and antinociceptive activity of methadone, buprenorphine, and diprenorphine: in vitro and in vivo evaluation.

Authors:  Hazem E Hassan; Alan L Myers; Andrew Coop; Natalie D Eddington
Journal:  J Pharm Sci       Date:  2009-12       Impact factor: 3.534

3.  Regulation of gene expression in brain tissues of rats repeatedly treated by the highly abused opioid agonist, oxycodone: microarray profiling and gene mapping analysis.

Authors:  Hazem E Hassan; Alan L Myers; Insong J Lee; Hegang Chen; Andrew Coop; Natalie D Eddington
Journal:  Drug Metab Dispos       Date:  2010-01       Impact factor: 3.922

Review 4.  Cholinergic modulation by opioid receptor ligands: potential application to Alzheimer's disease.

Authors:  William C Motel; Andrew Coop; Christopher W Cunningham
Journal:  Mini Rev Med Chem       Date:  2013-03       Impact factor: 3.862

Review 5.  Opioid analgesics and P-glycoprotein efflux transporters: a potential systems-level contribution to analgesic tolerance.

Authors:  Susan L Mercer; Andrew Coop
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

Review 6.  Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.

Authors:  Christopher W Cunningham; Richard B Rothman; Thomas E Prisinzano
Journal:  Pharmacol Rev       Date:  2011-03-28       Impact factor: 25.468

7.  Opioids and efflux transporters. Part 3: P-glycoprotein substrate activity of 3-hydroxyl addition to meperidine analogs.

Authors:  Susan L Mercer; Christopher W Cunningham; Natalie D Eddington; Andrew Coop
Journal:  Bioorg Med Chem Lett       Date:  2008-04-25       Impact factor: 2.823

8.  Evaluation of the P-glycoprotein (Abcb1) affinity status of a series of morphine analogs: comparative study with meperidine analogs to identify opioids with minimal P-glycoprotein interactions.

Authors:  Hazem E Hassan; Susan L Mercer; Christopher W Cunningham; Andrew Coop; Natalie D Eddington
Journal:  Int J Pharm       Date:  2009-04-05       Impact factor: 5.875

9.  Opioids and efflux transporters. Part 4: influence of N-substitution on P-glycoprotein substrate activity of noroxymorphone analogues.

Authors:  Matthew D Metcalf; Andrew D Rosicky; Hazem E Hassan; Natalie D Eddington; Andrew Coop; Christopher W Cunningham; Susan L Mercer
Journal:  Bioorg Med Chem Lett       Date:  2014-05-22       Impact factor: 2.823

10.  Opioids and efflux transporters. Part 2: P-glycoprotein substrate activity of 3- and 6-substituted morphine analogs.

Authors:  Christopher W Cunningham; Susan L Mercer; Hazem E Hassan; John R Traynor; Natalie D Eddington; Andrew Coop
Journal:  J Med Chem       Date:  2008-02-27       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.